Paul W. Burridge

9.8k total citations · 2 hit papers
84 papers, 6.4k citations indexed

About

Paul W. Burridge is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Paul W. Burridge has authored 84 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 29 papers in Cardiology and Cardiovascular Medicine and 19 papers in Biomedical Engineering. Recurrent topics in Paul W. Burridge's work include Pluripotent Stem Cells Research (49 papers), CRISPR and Genetic Engineering (27 papers) and 3D Printing in Biomedical Research (18 papers). Paul W. Burridge is often cited by papers focused on Pluripotent Stem Cells Research (49 papers), CRISPR and Genetic Engineering (27 papers) and 3D Printing in Biomedical Research (18 papers). Paul W. Burridge collaborates with scholars based in United States, India and Germany. Paul W. Burridge's co-authors include Joseph C. Wu, Joseph Gold, Elena Matsa, Jared M. Churko, Arun Sharma, Antje Ebert, Gordon Keller, Feng Lan, Nicholas M. Mordwinkin and Praveen Shukla and has published in prestigious journals such as Nature, Circulation and Journal of Clinical Investigation.

In The Last Decade

Paul W. Burridge

82 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemically defined generation of human cardiomyocytes

2014 1.1k citations Paul W. Burridge, Elena Matsa et al. Nature Methods profile →
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

2016 533 citations Paul W. Burridge, Yong Fuga Li et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul W. Burridge United States	38	4.4k	1.7k	1.7k	1.6k	1.2k	84	6.4k
Kenneth R. Boheler United States	44	4.9k 1.1×	1.4k 0.8×	1.9k 1.1×	894 0.5×	879 0.7×	140	6.9k
Izhak Kehat Israel	30	4.7k 1.0×	2.8k 1.6×	1.4k 0.8×	967 0.6×	1.1k 0.9×	49	6.4k
Alessandra Moretti Germany	37	4.8k 1.1×	2.4k 1.4×	1.7k 1.0×	709 0.4×	1.2k 1.0×	92	6.4k
Ronald A. Li United States	35	3.1k 0.7×	1.1k 0.6×	1.2k 0.7×	1.3k 0.8×	1.1k 0.9×	104	5.0k
Elena Matsa United States	22	2.8k 0.6×	893 0.5×	1.2k 0.7×	993 0.6×	869 0.7×	29	3.8k
Michel Pucéat France	44	4.1k 0.9×	1.8k 1.1×	1.6k 1.0×	382 0.2×	534 0.4×	123	5.7k
Antje Ebert United States	22	2.3k 0.5×	975 0.6×	769 0.5×	797 0.5×	542 0.4×	31	3.4k
Farah Sheikh United States	33	2.1k 0.5×	778 0.5×	1.8k 1.1×	985 0.6×	352 0.3×	86	4.3k
Donald R. Menick United States	36	2.8k 0.6×	648 0.4×	950 0.6×	490 0.3×	906 0.7×	93	4.2k
Haodi Wu United States	31	2.3k 0.5×	492 0.3×	1.2k 0.7×	806 0.5×	703 0.6×	56	3.6k

Countries citing papers authored by Paul W. Burridge

Since Specialization

Citations

This map shows the geographic impact of Paul W. Burridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Burridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Burridge more than expected).

Fields of papers citing papers by Paul W. Burridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Burridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Burridge. The network helps show where Paul W. Burridge may publish in the future.

Co-authorship network of co-authors of Paul W. Burridge

This figure shows the co-authorship network connecting the top 25 collaborators of Paul W. Burridge. A scholar is included among the top collaborators of Paul W. Burridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul W. Burridge. Paul W. Burridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fonoudi, Hananeh & Paul W. Burridge. (2025). NFE2L2 in the spotlight: a transcriptional clue to paediatric cancer treatment cardiotoxicity. European Heart Journal. 47(9). 1081–1083.

Chen, Chunlei, Jason Shapiro, Hsiang‐Chun Chang, et al.. (2024). Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient. eLife. 13. 1 indexed citations

Fullenkamp, Dominic E., Lisa Dellefave‐Castillo, Adi D. Dubash, et al.. (2024). Susceptibility to innate immune activation in genetically mediated myocarditis. Journal of Clinical Investigation. 134(13). 6 indexed citations

Fullenkamp, Dominic E., Ansel P. Amaral, Cory Holgren, et al.. (2023). Physiological stress improves stem cell modeling of dystrophic cardiomyopathy. Disease Models & Mechanisms. 17(6). 1 indexed citations

Gao, Bowen, Qizhi Liu, Faqing Huang, et al.. (2023). Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. 18(10). 1913–1924. 11 indexed citations

Lyra‐Leite, Davi M., Disheet Shah, Emily Pinheiro, et al.. (2023). Nutritional requirements of human induced pluripotent stem cells. Stem Cell Reports. 18(6). 1371–1387. 11 indexed citations

Chiang, David Y., Arie O. Verkerk, Babet van der Vaart, et al.. (2023). The Role of MAPRE2 and Microtubules in Maintaining Normal Ventricular Conduction. Circulation Research. 134(1). 46–59. 4 indexed citations

Magdy, Tarek & Paul W. Burridge. (2021). Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity. Pharmacogenomics. 22(1). 41–54. 5 indexed citations

Magdy, Tarek, Mariam Jouni, Hui–Hsuan Kuo, et al.. (2021). Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. 145(4). 279–294. 59 indexed citations

10.

Sapkota, Yadav, Na Qin, Matthew J. Ehrhardt, et al.. (2020). Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry. Cancer Research. 81(9). 2556–2565. 24 indexed citations

11.

Pérez-Hernández, Marta, Alejandra Leo‐Macías, Sarah Keegan, et al.. (2020). Structural and Functional Characterization of a Na _v 1.5-Mitochondrial Couplon. Circulation Research. 128(3). 419–432. 20 indexed citations

12.

Waas, Matthew, Marisol Romero‐Tejeda, Ellen Poon, et al.. (2019). Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry. Stem Cell Reports. 12(2). 395–410. 14 indexed citations

13.

Sharma, Arun, Paul W. Burridge, Wesley L. McKeithan, et al.. (2017). High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Science Translational Medicine. 9(377). 287 indexed citations

14.

Abilez, Oscar J., Evangeline Tzatzalos, Huaxiao Yang, et al.. (2017). Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells. 36(2). 265–277. 109 indexed citations

15.

Burridge, Paul W., Yong Fuga Li, Elena Matsa, et al.. (2016). Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nature Medicine. 22(5). 547–556. 533 indexed citations breakdown →

16.

Mahairaki, Vasiliki, Jiwon Ryu, Ann Peters, et al.. (2014). Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties. Stem Cells and Development. 23(24). 2996–3010. 75 indexed citations

17.

Burridge, Paul W., Elena Matsa, Praveen Shukla, et al.. (2014). Chemically defined generation of human cardiomyocytes. Nature Methods. 11(8). 855–860. 1122 indexed citations breakdown →

18.

Gu, Mingxia, Nicholas M. Mordwinkin, Nigel G. Kooreman, et al.. (2014). Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. European Heart Journal. 36(13). 806–816. 36 indexed citations

19.

Gu, Eugene, et al.. (2012). Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity. Theranostics. 2(4). 335–345. 94 indexed citations

20.

Burridge, Paul W., Susan A. Thompson, Seth H. Weinberg, et al.. (2011). A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability. PLoS ONE. 6(4). e18293–e18293. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact